106351-03-5
106351-03-5结构式
- 常用中文名：5-(((1S,3R,8S,9S,10R,13S,14S,17S)-1,3-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxy)pentan-2-one
- 常用英文名：5-(((1S,3R,8S,9S,10R,13S,14S,17S)-1,3-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxy)pentan-2-one
- CAS号：106351-03-5
- 分子式：C24H38O4
- 分子量：390.55600
- 发布时间：2016-02-19 16:13:39
- 更新时间：2025-08-25 21:16:25
| 英文名 | 5-(((1S,3R,8S,9S,10R,13S,14S,17S)-1,3-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxy)pentan-2-one |
|---|
| 分子式 | C24H38O4 |
|---|---|
| 分子量 | 390.55600 |
| 精确质量 | 390.27700 |
| PSA | 66.76000 |
| LogP | 4.03530 |
|
~80%
106351-03-5 |
| 文献：Kubodera; Miyamoto; Ochi; Matsunaga Chemical and Pharmaceutical Bulletin, 1986 , vol. 34, # 5 p. 2286 - 2289 |
|
~%
106351-03-5 |
| 文献：Kubodera; Miyamoto; Ochi; Matsunaga Chemical and Pharmaceutical Bulletin, 1986 , vol. 34, # 5 p. 2286 - 2289 |
| 上游产品 2 | |
|---|---|
| 下游产品 3 | |
![(1R,3S,5E)-5-[(2E)-2-[(3aS,7aS)-1-(4-hydroxy-4-methylpentoxy)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol结构式](https://image.chemsrc.com/caspic/022/106315-28-0.png)
![(2R,4S,4aR,4bR,6aS,7S,9aR,9bS,14aS)-7-((4-hydroxy-4-methylpentyl)oxy)-4a,6a-dimethyl-11,13-dioxo-12-phenyl-2,3,4,4a,4b,5,6,6a,7,8,9,9a,12,13-tetradecahydro-1H,11H-9b,14a-ethenobenzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-2,4-diyl diacetate结构式](https://image.chemsrc.com/caspic/350/106351-06-8.png)
![(1S,3R,9S,10R,13S,14S,17S)-17-((4-hydroxy-4-methylpentyl)oxy)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1,3-diol结构式](https://image.chemsrc.com/caspic/312/106351-07-9.png)